| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...985211F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0085211 |
| P932 | PMC publication ID | 3887025 |
| P698 | PubMed publication ID | 24416363 |
| P5875 | ResearchGate publication ID | 259701638 |
| P50 | author | Alessio Fasano | Q18686101 |
| Myron M. Levine | Q29564379 | ||
| Maria R Fiorentino | Q42768381 | ||
| P2093 | author name string | Marcelo B Sztein | |
| P2860 | cites work | PKC eta regulates occludin phosphorylation and epithelial tight junction integrity | Q24311692 |
| Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein | Q24315859 | ||
| Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole | Q24646749 | ||
| Identification and Analysis of Occludin Phosphosites: A Combined Mass Spectrometry and Bioinformatics Approach | Q27653352 | ||
| Possible involvement of phosphorylation of occludin in tight junction formation | Q41104367 | ||
| The enterocyte-like differentiation of the Caco-2 tumor cell line strongly correlates with responsiveness to cAMP and activation of kinase A pathway. | Q41446001 | ||
| CK2-dependent phosphorylation of occludin regulates the interaction with ZO-proteins and tight junction integrity. | Q41506361 | ||
| Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies | Q44633325 | ||
| Occludin phosphorylation in regulation of epithelial tight junctions. | Q45963248 | ||
| Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery | Q46613719 | ||
| Inoculum size in shigellosis and implications for expected mode of transmission | Q47172816 | ||
| Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea | Q47361536 | ||
| Prevalence of the genes for shigella enterotoxins 1 and 2 among clinical isolates of shigella in Israel. | Q48294010 | ||
| Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh | Q50584891 | ||
| Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. | Q51191281 | ||
| New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. | Q53579124 | ||
| A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. | Q54158784 | ||
| Prevalence of Shigella Enterotoxin 1 among Shigella Clinical Isolates of Diverse Serotypes | Q54601009 | ||
| Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine. | Q54712481 | ||
| Etiology of Diarrhea Among Travelers and Foreign Residents in Nepal | Q54742261 | ||
| Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns | Q64133569 | ||
| The pathology of Shigella flexneri infection in rhesus monkeys: an endoscopic and histopathological study of colonic lesions | Q68517654 | ||
| Local and systemic antibody responses to Shigella infection in rhesus monkeys | Q68944588 | ||
| Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection | Q69156182 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione | Q82788556 | ||
| Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon | Q33416439 | ||
| Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo | Q33617990 | ||
| A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis). | Q33676706 | ||
| A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1 | Q33678906 | ||
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
| A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion | Q34192675 | ||
| Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro | Q34224319 | ||
| Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo | Q34482917 | ||
| Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability | Q34561438 | ||
| Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function | Q34918139 | ||
| Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells | Q35003095 | ||
| Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains | Q35455031 | ||
| Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit | Q35598035 | ||
| Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein | Q36237286 | ||
| Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis | Q36363758 | ||
| In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines | Q36601934 | ||
| Occludin is a functional component of the tight junction. | Q36828867 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Movement along actin filaments of the perijunctional area and de novo polymerization of cellular actin are required for Shigella flexneri colonization of epithelial Caco-2 cell monolayers | Q36956026 | ||
| Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp | Q37010733 | ||
| Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability | Q37344103 | ||
| Modulation of tight junction structure and function by kinases and phosphatases targeting occludin | Q37982360 | ||
| The Shigella human challenge model | Q38035961 | ||
| Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer | Q38304743 | ||
| Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
| Development of an auxotrophic oral live Shigella flexneri vaccine | Q39227963 | ||
| Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea | Q39453145 | ||
| Shigella infection in a SCID mouse-human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine | Q39519990 | ||
| Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. | Q39569905 | ||
| Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells | Q39610195 | ||
| Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine | Q39655324 | ||
| Etiology and epidemiology of travelers' diarrhea in Asia | Q39737855 | ||
| Effects of enteropathogenic bacteria & lactobacilli on chemokine secretion & Toll like receptor gene expression in two human colonic epithelial cell lines. | Q39792532 | ||
| Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis | Q40211202 | ||
| Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs. | Q40314454 | ||
| Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2 | Q40687041 | ||
| Phosphorylation of occludin correlates with occludin localization and function at the tight junction | Q41070997 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | attenuated vaccine | Q1810913 |
| P304 | page(s) | e85211 | |
| P577 | publication date | 2014-01-09 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release | |
| P478 | volume | 9 |
| Q30252849 | Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts. |
| Q38776163 | Characterization of a multicomponent live, attenuated Shigella flexneri vaccine |
| Q49997335 | Cryptosporidium parvum disrupts intestinal epithelial barrier function via altering expression of key tight junction and adherens junction proteins |
| Q55167657 | Cytokine Tuning of Intestinal Epithelial Function. |
| Q37497781 | Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit |
| Q52691745 | Modulation of Intestinal Paracellular Transport by Bacterial Pathogens. |
| Q58327078 | Prolamins of maize and wheat differentially affect intestinal cells both in biopsies of celiac patients and CACO-2 cell line |
| Q39172391 | Reconstituted human polyclonal plasma-derived secretory-like IgM and IgA maintain the barrier function of epithelial cells infected with an enteropathogen |
| Q38760352 | Toxoplasma gondii Infection Promotes Epithelial Barrier Dysfunction of Caco-2 Cells. |
Search more.